| 000 | 01548 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513170354.0 | ||
| 264 | 0 | _c19990517 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0022-510X | ||
| 024 | 7 |
_a10.1016/s0022-510x(98)00302-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGokcil, Z | |
| 245 | 0 | 0 |
_aAlpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis. _h[electronic resource] |
| 260 |
_bJournal of the neurological sciences _cJan 1999 |
||
| 300 |
_a62-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 |
_aInosine Pranobex _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon Type I _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aSubacute Sclerosing Panencephalitis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOdabasi, Z | |
| 700 | 1 | _aDemirkaya, S | |
| 700 | 1 | _aEroglu, E | |
| 700 | 1 | _aVural, O | |
| 773 | 0 |
_tJournal of the neurological sciences _gvol. 162 _gno. 1 _gp. 62-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-510x(98)00302-5 _zAvailable from publisher's website |
| 999 |
_c10024421 _d10024421 |
||